March 10, 2025- Eli Lilly, a prominent American multinational pharmaceutical company, announced plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro (tirzepatide), in lucrative markets like India, Mexico, and Brazil in the second half of 2025. https://www.coherentmarketinsights.com/news/eli-lilly-to-launch-breakthrough-weight-loss-drug-in-emerging-markets-this-year-1166